The FDA removed 12 substances from Category 2 effective April 22, 2026 because the nominations were withdrawn by the nominators, not because the FDA cleared anything removal does not place a substance in Category 1 or on the 503A bulks list, so these compounds now sit in no FDA category at all
While their choices may help to inform the decision-making of plan sponsors in other industries, ultimately all employers will need to weigh the clinical and financial issues to ensure their benefit design reflects their philosophy, program objectives and fiscal reality.
availability has shifted due to regulatory changes
"Conscious behavioral and nutrition changes are a critical component for people on GLP-1 medications to enable sustainable health improvements for the long-term," said Dr
Can I permanently change my injection day
After a few weeks of treatment, you will notice a reduction in hunger and an increased feeling of fullness after meals